Though Demodex mites are often seen as unwelcome guests, they play an essential role in the skin’s ecosystem. By maintaining a healthy balance of oils and moisture, and seeking professional guidance ...

Rosacea treatments include topical creams and light therapy. The goal of treatment is to reduce inflammation. Find OTC and ...

If you've ever suffered from common skin conditions like rosacea, eczema or psoriasis, you know how uncomfortable the itching ...

Tarsus Pharmaceuticals' lotilaner shows strong market performance for Demodex blepharitis, but cautious investment due to ...

Ocular rosacea is believed to be caused by Demodex mite infestation, and there is evident interest and demand from eye care practitioners for such a product. Tarsus is currently finalizing the ...

Ocular Rosacea – Pursuing The Next Potentially ... and more than half of all cases are caused by an infestation of Demodex mites. This inflammatory condition affects the eyes and surrounding ...

Demodex mites are suspected of triggering inflammation, which then contributes to redness and blemishes characteristic of rosacea (Dermatology, February 2024). A sulfur-containing cleanser such as ...

If you have persistent or recurrent discoloration (change in the natural skin tone) on your face, an appearance of tiny superficial blood vessels on your cheeks and forehead, or dry, bloodshot eyes, ...

Experts associate rosacea with an overpopulation of mites on the skin called Demodex folliculorum. A study published in 2022 found that phototherapy, which involves controlled UV exposure ...

There are plenty of things that can cause facial redness—rosacea, eczema, a damaged skin barrier, flushing and inflammation, to name a few—but now there’s finally one product that can ease ...

This article highlights clinical and economic factors associated with Demodex blepharitis as well as diagnostic complexities, limitations of traditional therapies, the safety and efficacy of the 1 ...

IRVINE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in fireside chats at two upcoming investor conferences: ...